Lidocaine Ointment USP — Class II drug recall D-0013-2027
Ongoing recall by Preferred Pharmaceuticals, Inc., reported 2026-10-14, distributed nationwide. Failed Content Uniformity Specifications
| Recall number | D-0013-2027 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc., Anaheim, CA, United States |
| Recall initiated | 2026-09-28 |
| Classified | 2026-10-06 |
| Reported by FDA | 2026-10-14 |
| Distributed | Nationwide (US) |
| NDC | 68788-7865-05 |
| Lot numbers | D0825D, D3025M, E0925T, F1925G |
| Expiration dates | 2027-04-30 |
Product
Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
Reason for recall
Failed Content Uniformity Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0013-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.